enGene Holdings Inc.
General ticker "ENGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $424.5M (TTM average)
enGene Holdings Inc. follows the US Stock Market performance with the rate: 54.5%.
Estimated limits based on current volatility of 4.7%: low 6.78$, high 7.45$
Factors to consider:
- Total employees count: 33 as of 2023
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-10-31 to 2027-10-31
- 2025-10-31 to 2026-10-31 estimated range: [4.80$, 12.10$]
- 2026-10-31 to 2027-10-31 estimated range: [3.92$, 10.15$]
Short-term ENGN quotes
Long-term ENGN plot with estimates
Financial data
| YTD | 2025-10-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $123.17MM |
| Operating Income | $-123.17MM |
| Non-Operating Income | $5.86MM |
| Interest Expense | $2.99MM |
| R&D Expense | $94.48MM |
| Income(Loss) | $-117.30MM |
| Profit(Loss)* | $-117.30MM |
| Stockholders Equity | $167.71MM |
| Assets | $221.47MM |
| Operating Cash Flow | $-99.24MM |
| Capital expenditure | $1.49MM |
| Investing Cash Flow | $-25.14MM |
| Financing Cash Flow | $1.52MM |
| Earnings Per Share** | $-2.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.